- Febrile seizures, which are convulsions triggered by fever in young children, are gaining increasing clinical attention as pediatric neurological disorders, prompting advancements in diagnostic protocols and therapeutic interventions across both hospital and outpatient settings due to their recurring nature and potential impact on child development
- The rising incidence of febrile seizures, especially among infants aged 6 months to 5 years, is the key factor fueling market demand, along with growing awareness among parents, expanded access to pediatric neurology services, and increased use of antipyretic and anticonvulsant therapies
- North America dominated the febrile seizures market, with the largest revenue share of 39.2% in 2024, supported by well-established healthcare infrastructure, early diagnosis practices, and active research into pediatric seizure management, with the U.S. contributing significantly through hospital-led treatment programs and preventive care strategies
- Asia-Pacific is expected to witness the fastest growth in the febrile seizures market during the forecast period, attributed to growing pediatric populations, increasing healthcare expenditure, and rising public health awareness campaigns
- Simple febrile seizures segment dominated the febrile seizures market with a market share of 61.8% in 2024, driven by its higher prevalence compared to complex seizures and generally benign nature, making them more commonly diagnosed and managed
